創業集團(02221.HK)授出宜興項目建設工程合約 涉1.2億人民幣
創業集團(02221.HK)公布,附屬宜興公司與承包商江蘇巴朗建設工程訂立建造協議,授出宜興項目建設工程合約,代價為1.2億元人民幣,建設期預期為550天,至2024年12月31日結束。
承包商將負責環保產業園的建設、安裝、裝潢工作,以及宜興項目內配套設施等工程。
集團去年4月宣布,與中國政府機關中國宜興環保科技工業園管理委員會訂立合作協議,將在江蘇省宜興市投資建設真空多效膜蒸餾技術(V-MEMD)的生產研發基地項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.